Kestra Medical Technologies (KMTS) Research & Development (2024 - 2026)

Kestra Medical Technologies (KMTS) has 3 years of Research & Development data on file, last reported at $5.6 million in Q2 2026.

• On a quarterly basis, Research & Development rose 4.6% year-over-year to $5.6 million in Q2 2026; TTM through Apr 2026 was $19.5 million, a 24.49% increase from a year earlier, with the FY2026 full-year figure at $19.5 million, up 24.48% from the prior year.
• Research & Development for Q2 2026 stood at $5.6 million, up from $5.0 million in the prior quarter.
• Over the last five years, Research & Development for KMTS reached as high as $5.6 million in Q2 2026 and fell as low as $3.4 million in Q1 2025.
• Historically, Research & Development has averaged $4.3 million across 3 years, with a median of $3.9 million in 2024.
• Across the five-year window, Research & Development fell 10.23% in 2025 and jumped 48.29% in 2026, its largest moves.
• Year by year, Research & Development stood at $3.5 million in 2024, then jumped by 39.01% to $4.9 million in 2025, then rose by 15.5% to $5.6 million in 2026.
• Per Business Quant data, the three most recent Research & Development figures were $5.6 million in Q2 2026, $5.0 million in Q1 2026, and $4.9 million in Q4 2025.